Literature DB >> 8894385

ISEC: a program to calculate insulin secretion.

R Hovorka1, P A Soons, M A Young.   

Abstract

ISEC (Insulin SECretion) is a computer program which calculates pre-hepatic insulin secretion from plasma C-peptide measurements. The program uses a regression (population) model to derive parameters of C-peptide kinetics from subject's gender, type (normal, obese, non-insulin dependent diabetes mellitus), age, weight, and height. Insulin secretion is calculated as a piece-wise constant (step) function with flexible step length allowing for a fine resolution of the secretion profile between measurements. A constrained regularisation method of deconvolution is employed to carry out the calculations. The calculated profile satisfies three properties: (i) it fits the measurement within the given level of the measurement error, (ii) it is non-negative, and (iii) it has a minimum value of a regularisation criterion (norm of second differences) which quantifies the degree of deviation of the secretion profile from a straight line. Both theoretical aspects and specific features related to ISEC are considered. To exemplify the use of ISEC, pre-hepatic insulin secretion is calculated during meal tolerance test, frequently sampled intravenous glucose tolerance test, hyperinsulinaemic euglycaemic glucose clamp, and basal conditions with frequent sampling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894385     DOI: 10.1016/0169-2607(96)01755-5

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  51 in total

1.  Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery.

Authors:  Pedro Souteiro; Sandra Belo; João Sérgio Neves; Daniela Magalhães; Rita Bettencourt Silva; Sofia Castro Oliveira; Maria Manuel Costa; Ana Saavedra; Joana Oliveira; Filipe Cunha; Eva Lau; César Esteves; Paula Freitas; Ana Varela; Joana Queirós; Davide Carvalho
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

2.  A minimal C-peptide sampling method to capture peak and total prehepatic insulin secretion in model-based experimental insulin sensitivity studies.

Authors:  Thomas Lotz; Uli Göltenbott; J Geoffrey Chase; Paul Docherty; Christopher E Hann
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans.

Authors:  Christopher J Morris; Jessica N Yang; Joanna I Garcia; Samantha Myers; Isadora Bozzi; Wei Wang; Orfeu M Buxton; Steven A Shea; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

4.  Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.

Authors:  Michael Taulo Lund; Merethe Hansen; Stinna Skaaby; Sina Dalby; Mikael Støckel; Andrea Karen Floyd; Karsten Bech; Jørn Wulff Helge; Jens Juul Holst; Flemming Dela
Journal:  J Physiol       Date:  2015-06-17       Impact factor: 5.182

5.  Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.

Authors:  Colleen M Craig; Li-Fen Liu; Carolyn F Deacon; Jens J Holst; Tracey L McLaughlin
Journal:  Diabetologia       Date:  2016-12-14       Impact factor: 10.122

6.  High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients.

Authors:  Anette P Gjesing; Malene Hornbak; Kristine H Allin; Claus T Ekstrøm; Søren A Urhammer; Hans Eiberg; Oluf Pedersen; Torben Hansen
Journal:  Diabetologia       Date:  2014-03-07       Impact factor: 10.122

7.  GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.

Authors:  Lærke S Gasbjerg; Mikkel B Christensen; Bolette Hartmann; Amalie R Lanng; Alexander H Sparre-Ulrich; Maria B N Gabe; Flemming Dela; Tina Vilsbøll; Jens J Holst; Mette M Rosenkilde; Filip K Knop
Journal:  Diabetologia       Date:  2017-09-25       Impact factor: 10.122

8.  Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.

Authors:  A P Gjesing; C T Ekstrøm; H Eiberg; S A Urhammer; J J Holst; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2012-02-15       Impact factor: 10.122

9.  Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.

Authors:  Carsten Dirksen; Kirstine N Bojsen-Møller; Nils B Jørgensen; Siv H Jacobsen; Viggo B Kristiansen; Lars S Naver; Dorte L Hansen; Dorte Worm; Jens J Holst; Sten Madsbad
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

10.  No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.

Authors:  Carsten Dirksen; Aleksander Eiken; Kirstine N Bojsen-Møller; Maria S Svane; Christoffer Martinussen; Nils B Jørgensen; Jens J Holst; Sten Madsbad
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.